NCT02239224
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Facioscapulohumeral Muscular Dystrophy (FSHD), Genetic Diseases, Inborn, +7 more
- Locations
-
- aTyr Pharma Investigative Site Rochester, New York, United States
- aTyr Pharma Investigative Site Columbus, Ohio, United States
- aTyr Pharma Investigative Site Marseille, France
- aTyr Pharma Investigative Site Rome, Italy